Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-24-047639
Filing Date
2024-11-25
Accepted
2024-11-25 17:10:55
Documents
8

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 382231
2 ex5-1.htm EX-5.1 13329
3 ex23-2.htm EX-23.2 3982
4 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 15130
5 ex5-1_001.jpg GRAPHIC 25832
6 ex5-1_002.jpg GRAPHIC 24168
7 forms-3_001.jpg GRAPHIC 6197
8 forms-3_002.jpg GRAPHIC 31861
  Complete submission text file 0001493152-24-047639.txt   537573
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283449 | Film No.: 241496986
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)